BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1409 related articles for article (PubMed ID: 29518134)

  • 1. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi NJ; Feinberg J; Nielsen EE; Safi S; Gluud C; Jakobsen JC
    PLoS One; 2017; 12(10):e0186856. PubMed ID: 29073191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi NJ; Safi S; Feinberg J; Nielsen EE; Gluud C; Jakobsen JC
    Syst Rev; 2017 Apr; 6(1):71. PubMed ID: 28381269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi NJ; Safi S; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
    Syst Rev; 2017 Mar; 6(1):47. PubMed ID: 28264715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6():CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.
    Bedford J; Drikite L; Corbett M; Doidge J; Ferrando-Vivas P; Johnson A; Rajappan K; Mouncey P; Harrison D; Young D; Rowan K; Watkinson P
    Health Technol Assess; 2021 Nov; 25(71):1-174. PubMed ID: 34847987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials.
    Perrett M; Gohil N; Tica O; Bunting KV; Kotecha D
    Clin Res Cardiol; 2024 Jun; 113(6):831-841. PubMed ID: 37658166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis.
    Maagaard M; Nielsen EE; Sethi NJ; Liang N; Yang SH; Gluud C; Jakobsen JC
    BMJ Evid Based Med; 2022 Aug; 27(4):224-234. PubMed ID: 34789473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.
    Letelier LM; Udol K; Ena J; Weaver B; Guyatt GH
    Arch Intern Med; 2003 Apr; 163(7):777-85. PubMed ID: 12695268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological cardioversion for atrial fibrillation and flutter.
    Cordina J; Mead G
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003713. PubMed ID: 15846675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.
    Schreck DM; Rivera AR; Tricarico VJ
    Ann Emerg Med; 1997 Jan; 29(1):135-40. PubMed ID: 8998092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.